[1]
M. S. Pandrc, “Evaluation of a three-month trial of thyroxine replacement in symptomatic subclinical hypothyroidism: An impact on clinical presentation, quality of life and adoption of long-term therapy”, Vojnosanit Pregl, vol. 77, no. 9, Feb. 2021, doi: 10.2298/VSP180708157P.